IRCT20100520003979N9
Recruiting
Phase 2
The evaluation of atypical antipsychotic augmentation with Atomoxetine in the reduction of negative symptoms in patients with Schizophrenia
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Schizophrenia.
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Detection of schizophrenia based on the diagnosis of a faculty psychiatrist and an psychiatrist assistant with a clinical interview based on DSM\-5
- •Bold negative symptoms( PANSS negative symptom sub\-scale score more than 15\)
- •Not having liver disease
- •Suffering from the disease for more than a year
- •Age between 18 and 70 years.
Exclusion Criteria
- •Presence of Depression based on DSM\-5 Clinical Interview
- •Presence of Bipolar disorder
- •Pregnant or lactating woman
- •Substance abuse during the last month
- •patients suffering from Attention Deficit Hyperactivity Disorder (ADHD)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
egative symptom treatment in schizophrenia disorderSchizophrenia disorder.paranoid schizophrenia, hebephrenic schizophrenia, catatonic schizophrenia ,undiffrentiated schizophreniaIRCT138902113843N1Ahvaz Jundishapur University of Medical Sciences40
Completed
Not Applicable
The Effect of Sertraline In Treatment Of SchizophreniaIRCT2014041317246N1Vice Chancellor for Research and Technology Development-Ahwaz Jondishapur University of Medical Sci30
Completed
Not Applicable
Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in HungarySchizophreniaAffective SymptomsNCT01534936AstraZeneca2,153
Completed
Not Applicable
Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins.psychosisschizophrenia10039628NL-OMON31735GGZ Groep Noord en Midden-Limburg100
Completed
Not Applicable
Atypical antipsychotics for continuation and maintenance treatment after an acute manic episodeBipolar disorderMental and Behavioural DisordersISRCTN76555175niversity of British Columbia (Canada)540